Results of the summarizing process for the arXiv paper: 1910.05176v1

Depression and anxiety are common in cancer patients, but traditional antidepressants have not been proven effective compared to placebo. Recent studies have shown that a psilocybin-based therapy, which uses a serotoninergic hallucinogen, may be promising for treating these types of distress. The Heffter Institute is the main organization working on this topic. To examine whether psilocybin-based therapy could be considered safe and effective for cancer-related depression and anxiety, a systematic review was conducted following PRISMA guidelines. Both quantitative and qualitative studies were analyzed from PubMed and the Heffter Institute databases. The effects of psilocybin on cancer-related depression and anxiety were studied separately, as well as the psychological and neurobiological mechanisms involved. The review included four studies with 105 randomized patients. A meta-analysis on depression and anxiety using pooled Peto odds ratios showed that psilocybin was significantly superior to placebo. The substance also appeared to be safe for this type of patient. Surprisingly, new hypotheses about psychological mechanisms were discovered. In conclusion, psilocybin appears to be potentially useful as a treatment for cancer-related depression and anxiety. Future research should verify these findings on a wider population and seek ways to apply therapy to non-hospitalized (ambulatory) patients. This study provides hope for those suffering from cancer-related distress who have not found relief through traditional antidepressants. Further research is needed to fully understand the potential benefits of psilocybin-based therapy in treating these conditions.

• - Depression and anxiety are common in cancer patients
• - Traditional antidepressants have not been proven effective compared to placebo
• - Psilocybin-based therapy, which uses a serotoninergic hallucinogen, may be promising for treating cancer-related distress
• - The Heffter Institute is the main organization working on this topic
• - A systematic review was conducted following PRISMA guidelines to examine whether psilocybin-based therapy could be considered safe and effective for cancer-related depression and anxiety
• - Both quantitative and qualitative studies were analyzed from PubMed and the Heffter Institute databases
• - The review included four studies with 105 randomized patients
• - A meta-analysis on depression and anxiety using pooled Peto odds ratios showed that psilocybin was significantly superior to placebo
• - Psilocybin also appeared to be safe for this type of patient
• - New hypotheses about psychological mechanisms were discovered
• - Psilocybin appears to be potentially useful as a treatment for cancer-related depression and anxiety
• - Future research should verify these findings on a wider population and seek ways to apply therapy to non-hospitalized (ambulatory) patients.

1. Cancer patients often feel sad or worried. 2. Regular medicine for feeling better hasn't been very helpful. 3. A new type of therapy using a special drug called psilocybin might be good for helping cancer patients feel better. 4. The Heffter Institute is the main group working on this kind of therapy. 5. Scientists looked at four studies with 105 people to see if psilocybin was safe and helpful for cancer patients. Definitions- Depression: Feeling very sad and hopeless for a long time - Anxiety: Feeling worried, nervous, or scared - Antidepressants: Medicine that helps people feel less sad or anxious - Psilocybin: A drug made from certain mushrooms that can make people see things differently - Serotoninergic hallucinogen: A type of drug that affects the brain chemical serotonin and can cause people to see things that aren't really there - Systematic review: Looking at all the studies on a topic in a careful way to find out what they say overall - PRISMA guidelines: Rules for how to do a systematic review in a fair and accurate way - Meta-analysis: Combining data from several studies to get an overall idea of how well something works - Pooled Peto odds ratios: A way of measuring how much better one treatment is than another - Placebo: A fake medicine given to some people in a study so scientists can compare it to the real medicine - Psychological mechanisms

Psilocybin-Based Therapy for Cancer-Related Depression and Anxiety: A Systematic Review

Cancer patients often suffer from depression and anxiety, yet traditional antidepressants have not been proven effective compared to placebo. Recent studies suggest that psilocybin-based therapy, which uses a serotoninergic hallucinogen, may be promising in treating these types of distress. To examine whether this type of therapy could be considered safe and effective for cancer-related depression and anxiety, the Heffter Institute conducted a systematic review following PRISMA guidelines. This review included four studies with 105 randomized patients.

Methods

The Heffter Institute researchers analyzed both quantitative and qualitative studies from PubMed and their own databases. The effects of psilocybin on cancer-related depression and anxiety were studied separately, as well as the psychological and neurobiological mechanisms involved. A meta-analysis on depression and anxiety using pooled Peto odds ratios was also conducted to assess the effectiveness of psilocybin compared to placebo.

Results

The results showed that psilocybin was significantly superior to placebo in treating cancer-related depression and anxiety. It also appeared to be safe for this type of patient population. Surprisingly, new hypotheses about psychological mechanisms were discovered during the course of this study as well.

Conclusion

In conclusion, this systematic review provides evidence that psilocybin may be potentially useful as a treatment for cancer-related depression and anxiety when traditional antidepressants have not been successful or are not an option due to side effects or other factors. Future research should verify these findings on a wider population sample size while seeking ways to apply therapy to non-hospitalized (ambulatory) patients who cannot access hospital care due to financial or geographical constraints or other reasons outside their control.. This study provides hope for those suffering from cancer-related distress who have not found relief through traditional antidepressants so far; further research is needed in order to fully understand the potential benefits of psilocybin-based therapy in treating these conditions effectively without any adverse side effects or risks associated with its use